Vanguard Group’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Vanguard Group’s Portfolio TLMD Stock Details TLMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,588,838	Closed	-$7.74M	–	4689
2022 Q1	$7.74M	Sell	2,588,838 -40,154	-2%	-$88.4K	﹤0.01%	3284
2021 Q4	$3.37M	Sell	2,628,992 -151,536	-5%	-$304K	﹤0.01%	3822
2021 Q3	$6.28M	Buy	2,780,528 +136,742	+5%	+$491K	﹤0.01%	3512
2021 Q2	$15M	Buy	2,643,786 +1,170,875	+79%	+$7.79M	﹤0.01%	2994
2021 Q1	$9.27M	Hold	1,472,911	–	–	﹤0.01%	3188
2020 Q4	$11.5M	Buy	+1,472,911	New	+$13M	﹤0.01%	2920

Vanguard Group's TLMD Position: Q2 2022 in Review

Vanguard Group sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 2,588,838 shares — an estimated $7.74M sold.

Vanguard Group first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $15M in Q2 2021. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

Vanguard Group reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Vanguard Group sold 2,588,838 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $7.74M.
Vanguard Group first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
Vanguard Group's SOC Telemed, Inc. Class A Common Stock position peaked at $15M in Q2 2021.
0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.